The bHLH protein eHAND is a sensitive marker for cardiovascular precursors in the Xenopus embryo. The earliest site of expression is a broad domain within the lateral plate mesoderm of the tailbud embryo. This domain comprises precursors that contribute to the posterior cardinal veins in later stages. Surprisingly, expression is profoundly asymmetric at this stage and is random with respect to embryo side. XeHAND is also expressed in an anterior domain that encompasses the prospective heart region. Within the myocardium and pericardium, transcripts are also asymmetrically distributed, but in these tissues they are localised in a left-sided manner. Later in development XeHAND transcripts are largely restricted to the ventral aorta, aortic arches and venous inflow tract (sinus venosus) which flank the heart itself, but no expression is detected in neural crest derivatives at any stage. This demonstrates that patterns of XeHAND expression differ markedly amongst vertebrates and that in Xenopus, XeHAND expression identifies all of the earliest formed elements of the cardiovascular system. In animal cap explants, expression of XeHAND (but not other markers of cardiogenic differentiation) is strongly induced by ectopic expression of the TGFb family members, BMP-2 and BMP-4, but this can be blocked by coexpression of a dominant negative BMP receptor. This suggests that XeHAND expression in the embryo is regulated by the ventralising signals of bone morphogenetic proteins. High levels of expression are also detected in explants treated with high doses of activin A which induces cardiac muscle differentiation. No such effect is seen with lower doses of activin, indicating that a second pathway may regulate the XeHAND gene during cardiogenesis.
Introduction
The basic helix-loop-helix (bHLH) family of transcription factors are involved in the regulation of differentiation in a diverse range of cell types. The best studied subfamilies of bHLH factors are those involved in skeletal myogenesis and neurogenesis. In both cases, tissue-specific members of the family play roles in fate determination and terminal differentiation. The central role played by these transcription factors has prompted a search for further members of the bHLH family which may perform similar, pivotal roles in the differentiation of other cell types.
Two novel bHLH proteins, eHAND (Thing-1/HXT) and dHAND (Thing-2/HED), have recently been identified through their ability to from heterodimers with the ubiquitous bHLH protein, E12 (Cross et al., 1995; Cserjesi et al., 1995; Hollenberg et al., 1995; Srivastava et al., 1995) and comprise a distinct subfamily. In mouse embryos, their transcripts are expressed in complicated and overlapping patterns throughout early development. eHAND is strongly expressed in extraembryonic tissues (the early trophoblasts and differentiated giant cells) as well as the embryonic heart, elements of the cardiovascular system, the autonomic ganglia, the gut, and the pharyngeal arches. dHAND is expressed in many of the same embryonic tissues and in addition, is expressed in the maternally derived deciduum. Unlike eHAND, dHAND expression is absent from extraembryonic tissues.
Little is known about the functional roles of the HAND proteins in early development, nor have gene targets for these transcription factors been identified. In the mouse, embryos homozygous for a targeted interruption of dHAND fail to complete cardiac looping, and appear to lack the right ventricle and aortic arch arteries (Srivastava et al., 1997) . No comparable knockout of the eHAND gene has yet been reported but eHAND transcripts are detected predominantly on the left side of the myocardium prior to heart looping (Biben and Harvey, 1997) and this distribution is reversed in mutant embryos that show situs inversus. eHAND expression in the mouse thus appears to be regulated by the pathways that establish embryonic laterality. A functional role in cardiogenesis is suggested by the finding that left-sided eHAND expression is abolished in Nkx2-5 knock out embryos, which also fail to progress beyond the linear heart tube stage .
In contrast, studies of the HAND genes in chick development provide less clear cut evidence for the roles of these transcription factors. No asymmetry has been reported in the distribution of eHAND or dHAND transcripts within the heart tube, and attempts to inhibit the function of either using gene-specific antisense oligonucleotides have produced no apparent phenotype (Srivastava et al., 1995) . However, simultaneous inhibition of both HAND genes by antisense oligonucleotides does result in the arrest of cardiac development at the normal onset of cardiac looping . Despite the apparent differences between chick and mouse, in each species the HAND genes appear therefore to play an important role during cardiac morphogenesis. The precise nature of this role has yet to be established.
Here we show that in the amphibian, Xenopus laevis, the eHAND gene provides an early and sensitive marker for the developing vasculature of the early embryo. Strikingly, the onset of eHAND expression in a broad domain of the lateral mesoderm is randomly asymmetric with respect to embryo side, despite the well established observation that left-right laterality is already determined by this stage. The lateral domains apparently comprise mesenchymal vascular precursor cells and subsequently condense to mark the newly formed posterior cardinal veins. In the tailbud embryo, eHAND transcripts are also localised in an anterior, ventral domain that encompasses the heart primordium. Expression is detected throughout the embryonic heart tube and subsequently in both the developing heart, its major vessels and the aortic arches. Within the heart, transcripts are distributed asymmetrically, marking the left side of the myocardium and pericardium.
Using explant cultures, we also show that the XeHAND gene is activated in response to bone morphogenetic proteins, BMP-2 and BMP-4, which are believed to play a role in dorso-ventral patterning in the embryo (Graff, 1997) and are implicated in the induction of cardiogenic fate in anterior mesoderm (Lough et al., 1996; Schultheiss et al., 1997) . The explant assay provides a powerful assay to investigate the mechanisms that mediate regulation of XeHAND expression by the BMP signalling pathway. It may also facilitate studies of the formation of vascular precursors in the early embryo.
Results

Cloning of Xenopus eHAND
We screened a Xenopus adult heart cDNA library using the yeast two-hybrid system to look for heart-specific members of the bHLH family and isolated two overlapping partial cDNAs derived from the same gene. The open reading frame contained a bHLH domain which most closely matched that of eHAND/Thing-1/HXT, a bHLH transcription factor previously isolated from both mouse and chick (Cross et al., 1995; Cserjesi et al., 1995; Hollenberg et al., 1995) . Overlapping clones representing the entire cDNA were isolated from a random-primed tadpole cDNA library. The complete sequence and conceptual translation of XeHAND are shown in Fig. 1A .
The Xenopus protein shows extensive sequence similarity throughout its length with the chick and mouse eHAND proteins (71% and 62% identity, respectively). The bHLH domain of these proteins is much more highly conserved, the XeHAND bHLH region having 93% and 91% identity with the equivalent portion of the mouse and chick proteins (Fig. 1B) . In addition to the bHLH domain, there are two other regions of highly conserved residues shared by the eHAND proteins. One contains 22 amino acids immediately C-terminal to the bHLH domain and the second comprises the C-terminal 22 amino acids. BLAST searches of the database using these domains does not reveal any other proteins containing such domains, and it remains to be seen whether these homologies have any functional significance.
In addition to the vertebrate eHANDs, the Xenopus sequence shows considerable similarity to the closely related dHAND proteins (also termed Thing-2 or HED) which have been identified in chick and mouse (Cross et al., 1995; Hollenberg et al., 1995; Srivastava et al., 1995) . However, apart from the 22 amino acid carboxy terminal motif mentioned above which is shared by all the HAND proteins, the amino and carboxy terminal domains of XeHAND can readily be distinguished from those of chick or mouse dHAND (Fig. 1B) . Homology between XeHAND and the dHAND sequences is therefore largely restricted to the bHLH domain (86% identity).
XeHAND expression commences during gastrulation
We first examined XeHAND expression during early development using an RNase protection assay (Fig. 2) and a probe comprised entirely of 5′ untranslated region sequences. No maternal XeHAND transcripts were detected in the unfertilised egg but zygotic expression was readily detected from the neurula stage onwards (Nieuwkoop stage 14) . In long exposures, XeHAND transcripts were first detected in the late gastrula embryo (stage 12.5). The level of transcripts increased through subsequent development reaching a peak at the early tailbud stage. Lower levels were detected in later stages, remaining relatively constant in swimming tadpoles (stage 35). Older, feeding tadpoles (stage 42) showed a marked reduction in XeHAND expression, approximately to the level detected immediately after gastrulation.
Our protection assay probe always gave a prominent second product (or doublet) resulting from partial protection of the probe sequence. A similar partial protection product was also obtained with a variety of probes from either the coding or 3′ untranslated regions (data not shown) indicating the presence of transcripts from another XeHAND allele. (Coexpression of divergent alleles is not uncommon for Xenopus laevis, since it is a pseudotetraploid species (Bisbee et al., 1977) .)
XeHAND transcripts identify vascular precursors in the embryo
RNA wholemount in situ hybridisation revealed that the major domain of XeHAND expression comprised a broad wedge-shaped domain on the flank of the early tailbud embryos ( Fig. 3A; stage 24) . In contrast to the RNase protection assay results, earlier expression of XeHAND could not be detected by RNA whole-mount in situ hybridisation, regardless of the length or region of XeHAND used as the probe. This presumably reflects a difference in the sensitivity of the two techniques which we have frequently observed. Transverse sections of embryos stained in whole-mount showed that this expression was restricted to the lateral plate mesoderm (Fig. 4A) , its anterior ventral edge extending to the presumptive heart region of the embryo (Figs. 3A and 5E) .
Surprisingly, this expression in the lateral mesoderm was asymmetrical, with one side of the embryo having a consistently higher level of expression across a larger domain (compare the two sides of the same embryo in Fig. 3A and B). As development proceeded through tailbud stages (stages 27-32) the domain became more defined and restricted, but the initial asymmetry was retained (Fig. 3, compare C and D; E and F) .
By the swimming tadpole stage (stage 33/34) this expression was localised to a narrow band lying at the ventral margin of the myotomes (Fig. 4F) . The pronephric duct lies in a similar position but shows a distinct and irregular morphology (revealed by the marker PaxB) quite different from that of XeHAND staining (T. Carroll and P. Vize, pers. comm.). Furthermore, the pronephric duct lies in close apposition with the myotomes. Embryos labelled for both XeHAND and the myotomal muscle-specific marker XMLC1/3 showed a significant gap between the ventral margin of the myotomes and the XeHAND expression domain (Fig. 5A) indicating that the latter stained the newly forming posterior cardinal veins.
Some patchy staining for XeHAND was also detected in ventral regions of late tailbud embryos ( Fig. 3E,F ; indicated by the black arrow), which we presume corresponds to the vitelline veins, and both this and the staining of the posterior cardinal veins was maintained in feeding tadpoles (stages 42-46) . By this stage it is notable that expression of XeHAND on each side of the embryo was approximately equal.
The lateral domain of XeHAND shows random asymmetry
The initial appearance of XeHAND expression in the lateral mesoderm of early tailbud embryos was striking for its apparent asymmetry (Fig. 3) . Identical results were obtained with every batch of stained embryos, whether pigmented or albino. To investigate this further, we scored some embryos for sidedness of XeHAND expression at early tailbud (stages 22-25) and others from the same batch for the direction of gut looping at feeding tadpole stage (stage 42/46). XeHAND expression was randomly asymmetric whilst 90% of the same embryo batch showed a normal direction of gut looping (Table 1) . Danos and Yost (1996) have documented a 3-8% rate of spontaneous cardiac reversals in untreated batches of Xenopus embryos, which is similar to the 10% of embryos that we detected with reverse gut looping. These data confirm that the initial onset of XeHAND expression in lateral mesoderm was both asymmetric and random with respect to the left-right axis of the embryo.
A number of trivial explanations for this pattern are possible. Firstly, it could have been an artefact of the in situ staining technique, but this seems unlikely since embryos are agitated throughout the procedure. The staining pattern might also have resulted in some way from the random direction in which tailbud embryos bend within the vitelline membrane, prior to hatching. To test this possibility, tailbud embryos were sorted for direction of bending within their membrane and analysed by in situ hybridisation either immediately (stage 25) or at various stages after hatching. No correlation could be established between the direction of bending and sidedness of XeHAND expression in the embryo (Table 2) . 8, 10, 12.5, 14, 17, 20, 23, 34 , 42 embryo RNA, respectively. Two embryo equivalents of RNA (10 mg) was used in each case. Full-length protected fragments for each probe are indicated. As an internal control, a probe for XMax2 (which is expressed at constant levels throughout early development (Tonissen and Krieg, 1994) ) was included in the XeHAND assay. 
XeHAND is expressed throughout the heartforming region
In addition to the lateral domain, a second region of XeHAND expression was detected in the anterior ventral portion of early tailbud embryos (Fig. 3A, white arrow) . This corresponded to the presumptive heart tube, formed by fusion of the two cardiac anlagen along the anterior ventral midline (stage 19). Posterior to the heart forming tissue, ventral mesoderm forms the blood islands which can be identified by the expression of T4 a-globin (Walmsley et al., 1994) . Staining for these transcripts was clearly separated from both the lateral and anterior ventral regions of XeHAND expression in the early tailbud embryo (Fig.  SE) . A small area between the heart primordium and the blood islands was not stained with either probe (Fig. 5C , arrowhead). This region was immediately posterior to the liver diverticulum and corresponds to a region of ectoderm which has no underlying mesoderm (Walmsley et al., 1994) .
In order to assess the extent of XeHAND expression within the heart tube, we examined embryos stained for Embryos were fixed at tailbud stages, analysed for XeHAND expression by whole-mount in situ hybridisation and scored for sidedness of staining. As a control, embryos from the same batch were allowed to develop into feeding tadpoles (stage 46) and scored for the direction of gut looping. Embryos were sorted for direction of bending within the vitelline membrane at the tailbud stage (stage 25), membranes were removed manually and embryos allowed to straighten. Embryos were then either fixed immediately, or allowed to develop for various times before fixing. XeHAND expression was analysed by whole-mount in situ hybridisation and scored for sidedness of staining.
both XeHAND and the myocardial muscle-specific marker, XMLC2a (Fig. 5B-D) . At stage 28, XMLC2a was expressed in the two bilaterally symmetrical patches of the heart primordium, on either side of the midline (light blue), separated by a thin stripe of XeHAND expression (purple). XeHAND expression was also evident both anterior and posterior to the XMLC2a expression, in regions that form the ventral aorta and sinus venosus. By swimming tadpole stages, expression of XeHAND within the central portion of the heart region was reduced (Fig. 3G) and staining was largely confined to tissue surrounding the developing heart (Fig. 5C) . Staining anterior to the heart primordium corresponded to the ventral aorta and the aortic arches (Fig. 3G, white arrow) , whilst the region immediately posterior to the heart was the sinus venosus (Fig. 3G, black arrow) . Overstaining of embryos at these stages also revealed a residual level of XeHAND expression in the heart itself ( Fig. 3H, white arrow) . In later embryos, staining for XeHAND was detected in the ventral aorta, extending anterior from the heart (Fig. 5D , white arrow).
XeHAND expression is asymmetric in the forming heart
To determine the precise location of transcripts in this region, tailbud embryos (stage 33/34) stained in wholemount were sectioned in the transverse plane (Fig. 4B-E) . Most anteriorly, at the level of the eye vesicles, transcripts were detected in two patches in the head mesenchyme on either side of the foregut (Fig. 4B ). This expression domain corresponded to the first pair of aortic arches, which form at stage 31 from the ventral endocardial tube (Nieuwkoop and Faber, 1994) . In sections moving progressively more posterior, the patches of expression appeared to move towards the ventral surface of the embryo, and formed two horizontal lines, separated by the lumen of the ventral aorta (Fig. 4C , the lumen of the ventral aorta indicated by the black arrow). At the level of the anterior pericardial cavity (Fig. 4D ) expression levels were lower, and could be seen throughout the dorsal pericardium (black arrow). More posterior sections (Fig. 4E ) revealed that expression in the dorsal pericardium persisted (black arrow), but low levels of expression were also seen throughout the pericardium. In addition, prominent staining was evident in the left side of the myocardial layer surrounding the endocardial tube Fig.  4E , white arrow; higher magnification shown in Fig. 4G ). The restriction of XeHAND expression to the left-hand side of the myocardium surrounding the endocardial tube and its absence from the endocardium is reminiscent of the expression of eHAND in the mouse (Biben and Harvey, 1997; Srivastava et al., 1997) but contrasts with the distribution reported for chick embryos (Srivastava et al., 1995) .
XeHAND expression is maintained in the adult heart
Mouse eHAND has been detected in a wide variety of adult tissues including liver, smooth muscle of the gut (Hollenberg et al., 1995), brain, testis, skeletal muscle (Cross et al., 1995) ; intestine and adrenal tissue . Interestingly, despite its early expression in the embryonic heart tube, no transcripts have been detected in the adult heart. In contrast, XeHAND was highly expressed in the adult frog heart (Fig. 6, lane 9) . Lower levels were also found in intestine and gall bladder (Fig. 6, lanes 4 and 6) . Transcripts were undetectable in liver, spleen, stomach, lung or skeletal muscle, even after prolonged exposure of the autoradiograms.
XeHAND is activated by BMPs and FGF-2 in embryo explants
The bone morphogenetic proteins, BMP-2 and BMP-4 are thought to play an important role in dorso-ventral patterning in the early embryo. Both will induce ventral and posterior mesoderm markers in animal cap explants and in the embryo their ventralising activity is antagonised by signals from the organiser, such as noggin and chordin (reviewed in Graff, 1997) .
In tailbud embryos, transcripts of both BMPs are loca- Fig. 6 . Expression of XeHAND in adult frog tissues. The distribution of XeHAND mRNA in adult frog tissues was analysed by RNase protection assay. Lane 1, undigested probes; lane 2, tRNA control; lanes 3-11, tadpole embryo (stage 34), intestine, stomach, gall bladder, spleen, skeletal, heart, lung, liver RNA, respectively. Five micrograms of total RNA was used in each assay. Full-length protected fragments for each probe are indicated. As an internal control, a probe for the highly abundant EF1-a was included in the XeHAND assay.
lised to an anterior domain encompassing the prospective heart region and the posterior ventral region of the embryo (Fainsod et al., 1994; Clement et al., 1995; Hemmati-Brivanlou and Thomsen, 1995; Schmidt et al., 1995) . Since a low level of XeHAND expression was detected in similar regions ( Fig. 3A and B) , the patterns of BMP and XeHAND expression show considerable overlap. We therefore tested whether XeHAND transcription may in part be regulated by BMP signalling pathways. Low levels of BMP transcripts have been detected in the presumptive ectoderm of blastula embryos (Hemmati-Brivanlou and Thomsen, 1995) but no expression of XeHAND is detected in cultured animal cap explants (Fig. 7A, lane 1) . However, ectopic expression of either BMP-2 or BMP-4 resulted in robust expression of XeHAND in the explants, along with T4 a-globin, a marker for ventral mesoderm differentiation (Fig. 7A, lanes 2 and 3) . Both responses were blocked by coexpression of a dominant negative form of the BMP receptor (Suzuki et al., 1994 ; Fig. 7A , lanes 5 and 6). By contrast, no markers of either cardiac determination (tinman homologues XNkx2.5 and XNkx2.3) or terminal differentiation (XMLC2a) were detected in response to BMP-2 or BMP-4 expression (data not shown).
We also tested the ability of activin A and FGF-2 to induce XeHAND expression in animal caps from uninjected embryos (Fig. 7B) . Both of these factors induced mesoderm formation at a variety of doses, as judged by activation of skeletal muscle markers such as cardiac actin. FGF-2 strongly induced XeHAND expression at all doses tested (Fig. 7B, lanes 2-4) , consistent with its well documented ability to induce lateral and ventral mesoderm derivatives from explants of prospective ectoderm (Green et al., 1992) . In contrast, activin A induced little or no expression of XeHAND except at exceptionally high doses (Fig. 7B,  lanes 5-7) . At low doses, activin A is known to induce lateral as well as dorsal mesodermal markers (Green et al., 1992) but despite this, we found no effect on the XeHAND gene (data not shown). Not all treatments that induce lateral mesodermal derivatives will therefore induce the XeHAND gene. This suggests that activation of the XeHAND gene in these experiments is a specific response to FGF-2 treatment. Extremely high doses of activin induce dorso-anterior mesodermal derivatives, including skeletal muscle, notochord and endoderm. These treatments can also trigger cardiac differentiation (Logan and Mohun, 1993 ) most probably as a result of secondary interactions within the explant, rather than as a direct effect of the activin itself. This probably accounts for the onset of XeHAND expression under these conditions.
Discussion
XeHAND expression in the developing cardiovascular system
XeHAND expression provides a sensitive marker for all the earliest formed elements of the frog embryo cardiovascular system (heart, sinus venosus, ventral aorta, first aortic arches and posterior cardinal veins). These vessels form through vasculogenesis rather than angiogenesis (Risau and Flamme, 1995) . The inner, endothelial cells are formed by differentiation of angioblasts whilst the smooth muscle and pericyte components of the vessel wall are derived from mesenchymal cells that migrate to the newly forming vessel in response to a chemotactic signal (Folkman and D'Amore, 1996) . Comparison of XeHAND expression with that of the endothelial marker Xflk-1 (Cleaver et al., 1997) suggests that XeHAND is not expressed in the endothelial component of the developing vasculature, but in the adjacent mesenchyme. The progressive restriction of lateral XeHAND expression may therefore reflect migration of mesenchymal vascular precursors to the sites of posterior cardinal vein formation. Consistent with this, DiI lineage labelling studies show a dorsal movement of cells from lateral sites within the mesoderm during tailbud stages (data not shown). In the mouse embryo, eHAND expression has been reported in a variety of neural crest derivatives, such as the sympathetic trunk ganglia, pharyngeal arches, branchial arches, the septal region of the tongue and the adrenal medulla. Interestingly, we have not detected by in situ hybridisation any comparable expression of XeHAND transcripts in neural crest-derived structures of the Xenopus embryo. Taken together with the distribution of eHAND transcripts in the chick embryo, it is evident that there is considerable variation in eHAND expression patterns between vertebrates.
Asymmetry of XeHAND expression
Perhaps the most intriguing aspect of XeHAND expression is the dramatic asymmetry in its initial expression in the tailbud embryo. In contrast to the later left-sidedness in the myocardium, the initial sidedness within lateral mesoderm appears to be completely random. We know of no precedent for such a pattern, which commences many hours after the left/right signalling pathway is known to be established (Hyatt et al., 1996) . One possible explanation is to invoke a small, random disparity in the relative developmental stage of XeHAND expressing cells on each side of the embryo. If these cells are indeed vascular precursors, then a similar random asymmetry may be expected with other molecular markers for this cell type. Furthermore, embryos transgenic for a lineage reporter (such as GFP) under the control of the XeHAND gene regulatory elements should also show a similar-sided asynchrony in transgene expression.
Regulation of XeHAND expression
Embryo explant experiments demonstrate that XeHAND can be strongly activated in animal cap explants by the ventralising growth factors BMP-2 and BMP-4. Is this an indirect consequence of the induction of lateral/ventral mesoderm derivatives, or does it indicate a more intimate regulatory relationship between the XeHAND gene and the BMP signalling pathway? Recent studies of mutant heart phenotypes in zebrafish strongly suggest that BMP-4 lies upstream of eHAND in a regulatory hierarchy that controls asymmetric cardiac morphogenesis (see below). In frogs, this relationship can now be explored using the explant assay. It is possible for example to examine whether XeHAND is activated in response to putative mediators of BMP activity, such as the homeobox factor, Xom (Ladher et al., 1996) .
In chick embryos, BMPs have also been shown to induce cardiogenic differentiation and it has been proposed that the cardiogenic crescent arises as a result of these and the antagonistic effects of BMP regulators (such as noggin) on anterior mesoderm (Schultheiss et al., 1997) . It is not yet known if BMPs play a similar role in other vertebrates. In Xenopus, cardiac fate is determined during gastrulation Jacobson, 1989, 1990a,b; Nascone and Mercola, 1995) and there is currently no evidence to indicate a role for BMPs in this process. After neurulation, BMP-2 and BMP-4 transcripts are expressed in overlapping domains that encompass the heart primordium (Fainsod et al., 1994; Clement et al., 1995; Hemmati-Brivanlou and Thomsen, 1995; Schmidt et al., 1995) , suggesting a role for these factors in heart morphogenesis. Their precise distributions have not been compared in embryo sections and we do not know if they have similar or distinct roles in cardiogenesis. Differences in expression become evident in tadpole stages, with BMP-4 expression becoming confined largely to the ventral side of the branchial arches rather than the heart tube itself (Hemmati-Brivanlou and Thomsen, 1995) . This later expression pattern is remarkable similar to that of XeHAND in the ventral aorta (compare Fig. 5D with Fig. 3J in Hemmati-Brivanlou and Thomsen, 1995) .
Cardiac muscle differentiation can be induced in animal pole explants by treatment with extremely high doses of activin A (Logan and Mohun, 1993) , cardiogenic differentiation probably resulting from secondary inductive interactions between anterior character mesoderm and endoderm formed within the explant (Wright et al., 1989; Sasai et al., 1996) . Induction of XeHAND under these conditions is not due to formation of lateral mesoderm since lower doses of activin fail to induce the XeHAND gene. Rather, it reflects the induction of cardiogenic differentiation in the explants. Simultaneous treatment of animal caps with activin and BMPs neither increases the extent of cardiogenic differentiation at high activin doses nor extends the activin dose range which will activate cardiac markers (Mohun and Sparrow, unpublished data), indicating differentiation per se is not dependent on BMP signalling. If so, these data suggest two conclusions. Firstly, XeHAND expression during cardiogenesis is regulated by a second signalling pathway, independent of the BMPs; secondly, BMPs in the heart primordium may regulate cardiac morphogenesis rather than terminal differentiation.
eHAND expression and cardiac laterality
Heart looping provides a convenient marker for the analysis of laterality in the vertebrate embryo, but we do not know how this asymmetric morphogenetic process is regulated. Antisense experiments in the chick indicate a role for the HAND genes in the onset of heart tube looping but their precise function is unclear. Neither is apparently expressed asymmetrically within the heart tube and looping is only blocked by simultaneous inhibition of both genes (Srivastava et al., 1995) . In contrast, eHAND expression in the mouse embryo provides the first marker for the future direction of heart looping. The caudal domain of eHAND expression is initially bilateral and symmetrical within the linear heart tube, but it becomes predominantly left-sided in the myocardium and sinus venosus prior to the onset of rightward looping. As a result, eHAND expression becomes restricted largely to the atrium and left ventricle of the chambered heart. These results have prompted the suggestion that activity of the eHAND transcription factor mediates the influence of embryo laterality on cardiac morphogenesis (Biben and Harvey, 1997; Srivastava et al., 1997) .
Strikingly, in the zebrafish BMP-4 is expressed in a similar fashion. Like in the mouse (Biben and Harvey, 1997) , the zebrafish linear heart tube first 'jogs' to the left then loops to the right (Chen et al., 1997) . Although initially expressed symmetrically in the myocardium, BMP-4 expression becomes predominantly left-sided immediately prior to the leftward 'jog'. However, if BMP-4 expression is rendered more symmetric by overexpression, or if its signalling is interrupted by injection of a truncated receptor, the leftward 'jog' is blocked, and subsequent looping is disrupted. Likewise in mutants where the heart laterality is reversed and the heart 'jogs' to the right and loops to the left, BMP-4 is expressed predominantly on the opposite (right-hand) side of the myocardium to the wild-type embryos. Furthermore, in embryos in which the heart fails to 'jog' at all, BMP-4 expression is symmetrical throughout the myocardium.
Our findings of left sided XeHAND expression in the tadpole myocardium and that BMPs can activate XeHAND expression link these two observations and is consistent with BMP-4 being upstream of HAND genes in the process of heart looping. If this is the case, it is interesting to note that in the zebrafish other markers of cardiogenic determination such as MEF-2 and the tinman homologue Nkx2.5 are symmetrically expressed throughout the heart looping process, a result consistent with our failure to induce these markers by BMP expression in Xenopus animal cap explants. The molecular cues that establish left/right patterning in the embryo appear to be common amongst vertebrates (King and Brown, 1997) and in amphibians, these can be disrupted experimentally in several ways Yost, 1995, 1996) . It should therefore be possible to test the effect of such perturbations on the sidedness of XeHAND expression within the tadpole myocardium. In addition, we are currently investigating whether BMP-2 and BMP-4 are asymmetrically expressed in the Xenopus embryo.
Experimental procedures
Yeast two-hybrid screen
A cDNA library was made in yeast vector pGAD10 from poly A + RNA derived from adult Xenopus heart tissue using the Clontech MATCHMAKER kit according to the manufacturer's instructions. A library of approximately 2 × 10 7 independent clones with an average insert size of approximately 1.0 kb was generated, using a combination of oligo dT and random priming. A bait for the yeast two-hybrid screen (XE12-pGBT9) was constructed by fusing codons 507-658 encompassing the bHLH and carboxy terminal domains of Xenopus E 12 (Rashbass et al., 1992) in frame to the Gal4 DNA binding domain. The yeast strain YN166 (MATa gal4 gal80 trpl-901 ade2-101 leu2-3, -112 + URA::GAL → LacZ HIS3:: GAL(UAS) → Ura3), a gift of Steven Elledge (Baylor College of Medicine), was transformed with XE12-pGBT9 and grown in SD-Trp medium to an OD 600 of 0.4-0.6. 250 ml of culture was transformed with 200 mg of Xenopus adult heart cDNA library and 10 mg of salmon sperm carrier DNA by the lithium acetate method (Schiestl and Gietz, 1989 ) with dimethylsulfoxide addition to 10% final concentration (Hill et al., 1991) . For maximum transformation efficiency, the transformation mixture was divided into 10 aliquots of 1.5 ml for the heat shock step. After 2 h recovery in SD-Trp-Leu medium, the transformants were plated on medium to select for uracil prototrophy (SD-Trp-Leu-Ura). Approximately 7 × 10 5 independent cDNA clones were screened. Transformants expressing the Ura3 gene were tested for expression of the second reporter gene (LacZ) by b-galactosidase filter assay (Breeden and Nasmyth, 1985) . Library plasmids were recovered from double positive yeast colonies (Robzyk and Kassir, 1992) and sequenced. Two independent clones encoding the Xenopus eHAND gene were isolated. Both clones had the same 5′ end-point, and the larger clone, pXeHAND-y1, contained a polyA tail.
Isolation of full-length XeHAND cDNA
A random-primed cDNA library was constructed using RNA from stage 35 Xenopus embryos and the lZapII vector (Stratagene). The library contained approximately 10 6 independent clones with an average insert size of approximately 1.0 kb. This was screened with the entire coding region from pXeHAND-y1 PstD (nucleotides 257-761 of XeHAND cDNA sequence), at high stringency. Several positively hybridising cDNA clones were analysed and the entire XeHAND sequence was constructed as a composite from one of these clones (pXeHAND-3.1) and pXeHAND-y1. The composite sequence was analysed using DNA* (DNASTAR) and BLAST (at the NCBI using the BLAST network server: http://www.ncbi.nlm.-nih.gov/). The XeHAND nucleotide sequence has been submitted to the EMBL database under accession number Z95080.
RNA preparation and assay
RNA was prepared from embryos and adult tissues as described previously (Logan and Mohun, 1993) . XeHAND transcripts were detected with a probe consisting entirely of 5′ UTR (nucleotides 1-220). This was synthesised using EcoRI linearised template and T3 RNA polymerase. RNase protection assays were performed as described previously (Chambers et al., 1994) . Control probes for EF1a (Sargent and Bennett, 1990) and XMax2 (Tonissen and Krieg, 1994 ) were prepared as previously described.
Whole-mount RNA in situ hybridisation
Albino embryos (stages 14-46) were used for RNA whole-mount in situ hybridisation as described by Harland (1991) , using digoxigenin-labelled probes. The antisense XeHAND probe was derived from NotI linearised pXeHAND-y1 PstID (nucleotides 257-761) by using T3 RNA polymerase. A sense control probe was synthesised from XhoI linearised template with T7 RNA polymerase. A second anti-sense digoxygeninlabelled probe, consisting entirely of 5′ UTR sequence (nucleotides 1-220) was also used to confirm the specificity of the in situ expression pattern. Probes for T4 aglobin (Walmsley et al., 1994) , XMLC1/3 (Theze et al., 1995) , and XMLC2a (Chambers et al., 1994) were used for double-labelled in situ hybridisations. BCIP (Boehringer-Mannheim), Magenta-Phos (Biosynth AG) or NBT/ BCIP were employed for the chromogenic reactions. For histological analysis, fixed embryos were embedded in paraffin and 10 mm sections photographed under Nomarski optics.
Animal cap explant assays
Embryos were injected with 500-1000 pg of synthetic RNA at the one-or two-cell stage. Animal cap explants from injected and uninjected embryos were dissected at the blastula stage (stage 89) cultured overnight (Chambers et al., 1994) and harvested when sibling control embryos reached early tailbud stage (stage 20/21). Human recombinant activin A and Xenopus FGF-2 were kindly provided by Jim Smith (NIMR). Capped RNAs were transcribed (Chambers et al., 1994 ), using constructs previously described: BMP-4 (Dale et al., 1992) ; truncated BMP receptor (Suzuki et al., 1994 ) and a Xenopus BMP-2 clone (Nishimatsu et al., 1992) in the transcription vector pSP64T (kindly provided by Les Dale).
Reverse transcription-polymerase chain reaction (RT-PCR)
RNA from 15-20 explants was treated with DNAse 1 and one-tenth used for random primed cDNA synthesis. Onetenth of each cDNA sample was used for PCR amplification with the following primer pairs: XeHAND: (28 cycles) ACCCCTGATTGTTCTATTTGCC and GAATACAAT-TCTGGCTCATTGC; EF1a: (25 cycles) CAGATTGGT-GCTGGATATGC and ACTGCCTTGATGACTCCTAG; T4 a-globin: (28 cycles) AGCTGCCAAGCACATCGAT-GAC and GTGAGCTGTCCTTGCTGATACC; cardiac actin: (28 cycles) CTGACAGAATGCAGAAGG and GTTGCTTGGAGGAGTGTG. Under these cycle conditions, positive signals fell within a 10-20-fold range of reasonable linearity (data not shown).
32
P-labelled PCR products were resolved on native 4% acrylamide gels and exposed overnight..
